News

A team has developed a technology that is more than 30 times more sensitive than current lab-based tests in finding early stage cancer biomarkers in blood.

A team of scientists from Stanford University is working with researchers at the Molecular Foundry, a nanoscience user facility located at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), to develop a gene-targeting, antiviral agent against COVID-19.

Researchers have revealed the first structures of α-synuclein filaments from human brain, which may benefit diagnosis and treatment of neurodegenerative synucleinopathies.

Van Andel Institute scientists have revealed the first known atomic structure of a "molecular machine" responsible for installing critical signaling proteins into cellular membranes.

Researchers have found 27 potential biomarkers that are present in different levels in patients with COVID-19, depending on the severity of their symptoms. The markers could help doctors to predict how ill a patient will become and provide scientists with new targets for drug development.

Researchers have discovered a way to replace a missing protein in the brain of mice modeling Fragile X syndrome.

In a new study, researchers at the Centre for Genomic Regulation (CRG), in Barcelona, describe a new method for determining active metabolic pathways in microbes using cutting-edge techniques from genomics and proteomics.

Researchers have suggested that the inhibition of two key proteases on the surface of host cells could prevent SARS-CoV-2 from being able to invade.

A new coalition of more than 500 scientists from around the world has been created to share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.

A team of researchers led by Swansea University have developed new technology to monitor cholesterol in brain tissue which could uncover its relation to neurodegenerative disease and pave the way for the development of new treatments.